More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Forbes, Fox Business, U.S. News & World Report Among Media Outlets Featuring Medical Marijuana, Inc.

Forbes, Fox Business, U.S. News & World Report Among Media Outlets Featuring Medical Marijuana, Inc.

by adminAdrianRamirez | Jun 17, 2019 | Kannaway, Media Coverage

CBD and potential FDA regulation, CBD in Europe, and CBD disrupting the direct selling market lead our company headlines this week. Medical Marijuana, Inc. and our family of companies were at the center of numerous news stories this week as our efforts to expand...
Forbes, Fox Business, U.S. News & World Report Among Media Outlets Featuring Medical Marijuana, Inc.

FORBES, FOX BUSINESS, U.S. NEWS UND WORLD REPORT UNTER DEN MEDIEN, DIE ÜBER MEDICAL MARIJUANA, INC. BERICHTEN

by adminAdrianRamirez | Jun 17, 2019 | Kannaway, Media Coverage

CBD UND EINE MÖGLICHE REGULIERUNG DER FDA, CBD IN EUROPA UND CBD, DIE DEN DIREKTVERTRIEBSMARKT STÖRT, FÜHREN DIESE WOCHE DIE SCHLAGZEILEN UNSERES UNTERNEHMENS AN. Medical Marijuana, Inc. und unsere Unternehmensfamilie standen im Mittelpunkt zahlreicher Nachrichten in...
Medical Marijuana, Inc. Subsidiary Kannaway® Expands International Leadership Team with Peter Dale as General Manager of Japan Division

Medical Marijuana, Inc. Subsidiary Kannaway® Expands International Leadership Team with Peter Dale as General Manager of Japan Division

by adminAdrianRamirez | Jun 4, 2019 | Kannaway, Press Releases

SAN DIEGO, June 4, 2019 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today...
Medical Marijuana, Inc. Subsidiary Kannaway® Announces First-Ever Authorization in Bulgaria to Sell Hemp-Derived CBD Products

Medical Marijuana, Inc. Subsidiary Kannaway® Announces First-Ever Authorization in Bulgaria to Sell Hemp-Derived CBD Products

by adminAdrianRamirez | May 28, 2019 | Kannaway, Press Releases

SAN DIEGO, May 28, 2019 — Medical Marijuana, Inc. (OTC:MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...
Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New CBD Coffee and Tea Pods

Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New CBD Coffee and Tea Pods

by adminAdrianRamirez | May 7, 2019 | Kannaway, Press Releases

SAN DIEGO, May 7, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Kannaway® has released its new Single-Serving Coffee and Tea Pods, infused with 10 mg of...
KANNAWAY®, DIE TOCHTERGESELLSCHAFT VON MEDICAL MARIJUANA, INC., ALS GEWINNER VON GOLD STEVIE® AWARD IN 2019 AMERICAN BUSINESS AWARDS® GEEHRT

KANNAWAY®, DIE TOCHTERGESELLSCHAFT VON MEDICAL MARIJUANA, INC., ALS GEWINNER VON GOLD STEVIE® AWARD IN 2019 AMERICAN BUSINESS AWARDS® GEEHRT

by adminAdrianRamirez | May 2, 2019 | Kannaway, Press Releases

SAN DIEGO, 2. Mai 2019 – Medical Marijuana, Inc. (OTC:MJNA) gab heute bekannt, dass seine Tochtergesellschaft Kannaway®, das erste Hanf-Lifestyle-Netzwerk, das Cannabidiol (CBD) botanische Hanfprodukte anbietet, in der Kategorie „Medium Company of the Year –...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.